Nationwide Fund Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Nationwide Fund Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-92	Closed	-$22K	–	3291
2017 Q1	$22K	Hold	92	–	–	﹤0.01%	3082
2016 Q4	$25K	Hold	92	–	–	﹤0.01%	3073
2016 Q3	$20K	Hold	92	–	–	﹤0.01%	3123
2016 Q2	$36K	Buy	+92	New	+$100K	﹤0.01%	3112
2015 Q2	–	Sell	-100	Closed	-$225K	–	3371
2015 Q1	$225K	Sell	100 -8	-7%	-$13.6K	﹤0.01%	2634
2014 Q4	$111K	Buy	108 +2	+2%	+$2.14K	﹤0.01%	2884
2014 Q3	$112K	Buy	106 +1	+1%	+$1.68K	﹤0.01%	2943
2014 Q2	$263K	Buy	105 +17	+19%	+$34.7K	﹤0.01%	2608
2014 Q1	$168K	Buy	88 +9	+11%	+$21.3K	﹤0.01%	2562
2013 Q4	$170K	Buy	79 +6	+8%	+$14.2K	﹤0.01%	2765
2013 Q3	$165K	Buy	73 +5	+7%	+$9.67K	﹤0.01%	2759
2013 Q2	$118K	Buy	+68	New	+$108K	﹤0.01%	2736

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Nationwide Fund Advisors's AMPE Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2017, closing a stake of 92 shares — an estimated $22K sold.

Nationwide Fund Advisors first reported a position in AMPE in Q2 2013 and held it in 12 quarters. The position peaked at $263K in Q2 2014. 56 funds tracked by Wall St. Rank hold AMPE as of Q2 2017.

Nationwide Fund Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 92 Ampio Pharmaceuticals Inc. shares in Q2 2017, an estimated $22K.
Nationwide Fund Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 12 quarters.
Nationwide Fund Advisors's Ampio Pharmaceuticals Inc. position peaked at $263K in Q2 2014.
56 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.